These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 36947981

  • 1. Radical prostatectomy findings in patients with locally aggressive Grade group 5 prostatic adenocarcinoma and negative limited or extended pelvic lymph node dissection.
    Mallikarjunappa SS, Osunkoya AO.
    Pathol Res Pract; 2023 Apr; 244():154415. PubMed ID: 36947981
    [Abstract] [Full Text] [Related]

  • 2. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and 68 Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer.
    Franklin A, Yaxley WJ, Raveenthiran S, Coughlin G, Gianduzzo T, Kua B, McEwan L, Wong D, Delahunt B, Egevad L, Samaratunga H, Brown N, Parkinson R, Roberts MJ, Yaxley JW.
    BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
    [Abstract] [Full Text] [Related]

  • 3. Incidence, location, and significance of periprostatic and periseminal vesicle lymph nodes in prostate cancer.
    Kothari PS, Scardino PT, Ohori M, Kattan MW, Wheeler TM.
    Am J Surg Pathol; 2001 Nov; 25(11):1429-32. PubMed ID: 11684961
    [Abstract] [Full Text] [Related]

  • 4. Which Patients with Clinically Node-positive Prostate Cancer Should Be Considered for Radical Prostatectomy as Part of Multimodal Treatment? The Impact of Nodal Burden on Long-term Outcomes.
    Gandaglia G, Soligo M, Battaglia A, Muilwijk T, Robesti D, Mazzone E, Barletta F, Fossati N, Moschini M, Bandini M, Joniau S, Karnes RJ, Montorsi F, Briganti A.
    Eur Urol; 2019 May; 75(5):817-825. PubMed ID: 30409676
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: implications for patient selection in the radiotherapeutic management of prostate cancer.
    Stock RG, Stone NN, Ianuzzi C, Unger P.
    Int J Radiat Oncol Biol Phys; 1995 Nov 01; 33(4):815-21. PubMed ID: 7591888
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer.
    Gandaglia G, Fossati N, Zaffuto E, Bandini M, Dell'Oglio P, Bravi CA, Fallara G, Pellegrino F, Nocera L, Karakiewicz PI, Tian Z, Freschi M, Montironi R, Montorsi F, Briganti A.
    Eur Urol; 2017 Oct 01; 72(4):632-640. PubMed ID: 28412062
    [Abstract] [Full Text] [Related]

  • 10. Bilateral lymph node micrometastases and seminal vesicle invasion associated with same clinical predictors in localized prostate cancer.
    Porcaro AB, de Luyk N, Corsi P, Sebben M, Tafuri A, Tamanini I, Processali T, Cerruto MA, Migliorini F, Brunelli M, Siracusano S, Artibani W.
    Tumori; 2017 May 12; 103(3):299-306. PubMed ID: 27716882
    [Abstract] [Full Text] [Related]

  • 11. Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer.
    Yuh BE, Ruel NH, Mejia R, Wilson CM, Wilson TG.
    Eur Urol; 2012 May 12; 61(5):1004-10. PubMed ID: 22366188
    [Abstract] [Full Text] [Related]

  • 12. [Extended sentinel lymph node dissection in radical prostatectomy for prostate cancer: a study in the Kiel risk population].
    Hautmann S, Beitz S, Naumann M, Lützen U, Seif C, Stübinger SH, van der Horst C, Braun PM, Leuschner I, Henze E, Jünemann KP.
    Urologe A; 2008 Mar 12; 47(3):299-303. PubMed ID: 18273596
    [Abstract] [Full Text] [Related]

  • 13. Risk of lymph node metastases in pathological gleason score≤6 prostate adenocarcinoma: Analysis of institutional and population-based databases.
    Wenger H, Weiner AB, Razmaria A, Paner GP, Eggener SE.
    Urol Oncol; 2017 Jan 12; 35(1):31.e1-31.e6. PubMed ID: 27692833
    [Abstract] [Full Text] [Related]

  • 14. Management of Patients with Node-positive Prostate Cancer at Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review.
    Marra G, Valerio M, Heidegger I, Tsaur I, Mathieu R, Ceci F, Ploussard G, van den Bergh RCN, Kretschmer A, Thibault C, Ost P, Tilki D, Kasivisvanathan V, Moschini M, Sanchez-Salas R, Gontero P, Karnes RJ, Montorsi F, Gandaglia G, EAU-YAU Prostate Cancer Working Party.
    Eur Urol Oncol; 2020 Oct 12; 3(5):565-581. PubMed ID: 32933887
    [Abstract] [Full Text] [Related]

  • 15. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
    Gacci M, Schiavina R, Lanciotti M, Masieri L, Serni S, Vagnoni V, Abdollah F, Carini M, Martorana G, Montorsi F.
    Urol Int; 2013 Oct 12; 90(3):277-82. PubMed ID: 23296120
    [Abstract] [Full Text] [Related]

  • 16. Pelvic lymph node dissection in prostate cancer.
    Briganti A, Blute ML, Eastham JH, Graefen M, Heidenreich A, Karnes JR, Montorsi F, Studer UE.
    Eur Urol; 2009 Jun 12; 55(6):1251-65. PubMed ID: 19297079
    [Abstract] [Full Text] [Related]

  • 17. Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy.
    von Bodman C, Godoy G, Chade DC, Cronin A, Tafe LJ, Fine SW, Laudone V, Scardino PT, Eastham JA.
    J Urol; 2010 Jul 12; 184(1):143-8. PubMed ID: 20478587
    [Abstract] [Full Text] [Related]

  • 18. Differing risk of cancer death among patients with lymph node metastasis after radical prostatectomy and pelvic lymph node dissection: identification of risk categories according to number of positive nodes and Gleason score.
    Schiavina R, Borghesi M, Brunocilla E, Manferrari F, Fiorentino M, Vagnoni V, Baccos A, Pultrone CV, Rocca GC, Rizzi S, Martorana G.
    BJU Int; 2013 Jun 12; 111(8):1237-44. PubMed ID: 23331345
    [Abstract] [Full Text] [Related]

  • 19. Effect of Extended Pelvic Lymph Node Dissection on Oncologic Outcomes in Patients with D'Amico Intermediate and High Risk Prostate Cancer Treated with Radical Prostatectomy: A Multi-Institutional Study.
    Preisser F, van den Bergh RCN, Gandaglia G, Ost P, Surcel CI, Sooriakumaran P, Montorsi F, Graefen M, van der Poel H, de la Taille A, Briganti A, Salomon L, Ploussard G, Tilki D, EAU-YAUWP.
    J Urol; 2020 Feb 12; 203(2):338-343. PubMed ID: 31437119
    [Abstract] [Full Text] [Related]

  • 20. Pathologic nodal staging scores in patients treated with radical prostatectomy: a postoperative decision tool.
    Kluth LA, Abdollah F, Xylinas E, Rieken M, Fajkovic H, Sun M, Karakiewicz PI, Seitz C, Schramek P, Herman MP, Becker A, Loidl W, Pummer K, Nonis A, Lee RK, Lotan Y, Scherr DS, Seiler D, Chun FK, Graefen M, Tewari A, Gönen M, Montorsi F, Shariat SF, Briganti A.
    Eur Urol; 2014 Sep 12; 66(3):439-46. PubMed ID: 23850255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.